Background-Prosthetic orifice area, usually calculated by transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE), provides important information regarding the hemodynamic performance of aortic bioprostheses. However, both TTE and TEE have limitations; therefore accurate and reproducible determination of the orifice area often remains a challenge. The present study aimed to investigate the feasibility of cardiovascular magnetic resonance (CMR) to assess the orifice areas of aortic bioprostheses. Methods and Results-CMR planimetry of the orifice area was performed in 65 patients (43/22 stented/stentless prostheses; mean time since implantation, 3.1Ϯ2.8 years; mean orifice area [TTE], 1.70Ϯ0.43 cm 2 ; 62 normally functioning prostheses, 2 severe stenoses, and 1 severe regurgitation) in an imaging plane perpendicular to the transprosthetic flow using steady-state free-precession cine imaging under breath-hold conditions on a 1.5-T MR system. CMR results were compared with TTE (continuity equation, nϭ65) and TEE (planimetry, nϭ31). CMR planimetry was readily feasible in 80.0%; feasible with limitation in 15.4% because of stent, flow, and sternal wire artifacts; and impossible in 4.6% because of flow artifacts. Correlations of the orifice areas by CMR with TTE (rϭ0.82) and CMR with TEE (rϭ0.92) were significant. The average difference between the methods was Ϫ0.02Ϯ0.24 cm 2 (TTE) and 0.05Ϯ0.15 cm 2 (TEE). Agreement was present for stented and stentless devices and independent of orifice size. Intraobserver and interobserver variabilities of CMR planimetry were 6.7Ϯ5.4% and 11.5Ϯ7.8%.
T he prosthetic orifice area provides important information regarding the hemodynamic performance of aortic bioprostheses after aortic valve replacement. It is usually calculated by transthoracic echocardiography (TTE) using the continuity equation 1, 2 or by direct planimetry using TTE 3 or transesophageal echocardiography (TEE). 4 However, limited acoustic windows and observer dependence may lead to ambiguous results when using TTE, whereas the semi-invasive character of TEE limits its use for routine follow-up. Thus, although echocardiography remains the clinical standard for the majority of patients, in selected patients a noninvasive and objective alternative for the assessment of prosthetic orifice area is desirable.
Clinical Perspective on p 404
Cardiovascular magnetic resonance (CMR) is a highly standardized imaging method capable of visualizing struc-tures in multiple planes with known low observer variability and is virtually independent of patient physique. Rapid dynamic acquisition techniques with remarkable bloodtissue contrast and that require only short breath-hold periods, have become widely available with clinical MR systems. The use of CMR planimetry to quantify native aortic stenosis has already been approved and demonstrated to have strong agreement with both echocardiography and invasive measurements. [5] [6] [7] Furthermore, CMR became an American College of Cardiology Foundationapproved method for the characterization of cardiac valves in 2006. 8 CMR has already been successfully applied to the investigation of the flow profiles of stentless and stented bioprostheses 9 as well as to the analysis of left ventricular mass regression after aortic valve replacement. 10 The present study focuses on the feasibility of CMR to assess the orifice area of aortic bioprostheses.
Methods

Study Design
We prospectively compared orifice areas obtained by CMR planimetry with the results of TTE (continuity equation) and TEE (planimetry) in patients with biological aortic valve replacement.
Patient Population
We prospectively screened 264 patients with aortic valve replacement who underwent TTE in our department (from August 2007 to August 2008) for entry into the study. Inclusion criteria were an aortic bioprosthesis and a sufficient transthoracic acoustic window to allow for correct calculation of the prosthetic orifice area. Exclusion criteria were general contraindications for CMR. 11 Sixty-five patients were eligible for the study. Their initial indication for echocardiography was routine follow-up (nϭ40); early postoperative assessment (nϭ8); clinical suspicion of prosthetic dysfunction (nϭ14); and screening before noncardiac (nϭ2) or cardiac (nϭ1) interventions. Patients were only enrolled in the study if their bioprosthesis had been demonstrated to be safe and compatible with CMR procedures. Patient characteristics and distribution of valve types are depicted in the Table. One hundred ninety-nine patients did not meet the inclusion criteria: 6 patients declined to participate in the study; 109 patients had mechanical valves; 3 had homografts; 34 had permanent pacemakers or implantable cardioverter-defibrillators; 14 had other clinical conditions that did not allow CMR (nϭ4 severe orthopnea, nϭ2 claustrophobia, nϭ1 dementia, nϭ1 coma, nϭ1 shell splinter injury, nϭ2 artificial ventilation, nϭ3 senility); 2 had severe obesity; and 30 (11.4%) had an insufficient acoustic window. One patient met the inclusion criteria but died before CMR was performed.
The institutional ethics committee approved the study, and all patients provided written informed consent to participate.
TTE
TTE was performed in all 65 patients by experienced sonographers on a state-of-the-art ultrasound system (General Electric Healthcare, Vivid 7, Waukesha, Wis). Prosthetic orifice area was obtained using the continuity equation and transprosthetic pressure gradients using the modified Bernoulli equation in accordance with international guidelines. 12
TEE
TEE was performed in a subgroup of 31 patients either on a voluntary basis or because it was clinically indicated (eg, suspicion of endocarditis). The procedure was conducted by experienced sonographers with a multiplane transducer. Patients were prepared with local pharyngeal anesthesia. Intravenous midazolam was administered at the discretion of the physician. Prosthetic orifice area was quantified by planimetry in the short-axis view.
CMR
All 65 patients underwent CMR in a clinical 1.5-T MR scanner with a 12-element cardiac phased-array receiver coil (Magnetom Avanto, Siemens Healthcare, Erlangen, Germany). For prosthetic orifice visualization, ECG gating and parallel imaging were used, with steady-state free-precession (SSFP) cine images acquired during expiratory breath-holds. Imaging parameters were slice thickness, 5 mm; no gap; repetition time (TR), 2.9 ms; echo time (TE), 1.2 ms; flip angle (FA), 80°; field of view (FOV), typically 340 mm; matrix, 256ϫ146; bandwidth, 930 Hz/px; and 30 phases per R-R interval. Positioning of the cine loops for orifice planimetry was performed in a stepwise fashion to ensure accurate positioning of the imaging plane in the origin of the transprosthetic jet, as described by our group previously for aortic valve planimetry. 5 In brief, based on the 3-chamber view, 2 subsequent planes were positioned centrally in the direction of the transprosthetic jet to obtain a stack of slices perpendicular to the jet. Planimetry of the largest systolic orifice area was performed in a single frame using the software CMR 42 (CIRCLE Cardiovascular Imaging, Calgary, Alberta, Canada) ( Figure 1 ). In some patients showing significant flow artifacts on SSFP, additional fast gradient echo cine loops (FGRE) were acquired because of their lower susceptibility to turbulent flow (imaging parameters: slice thickness, 5 mm; no gap; TR, 6.5 ms; TE, 3.1 ms; FA, 15°; FOV, 340 mm; matrix, 192ϫ125; bandwidth, 260 Hz/px; and 25 phases per R-R interval).
Examination of ventricular function was performed by acquisition of SSFP cine images in standard long-axis planes (slice thickness, 6 mm, TR, 2.9 ms, TE, 1.2 ms; FA, 80°, FOV, 340 mm; matrix, 192ϫ156; bandwidth, 704 Hz/px; 30 phases per R-R interval). Where there were wall motion abnormalities, a stack of short axes covering the whole left ventricle was acquired (slice thickness, 7 mm; gap, 3 mm; TR, 2.7 ms; TE, 1.1 ms; FA, 80°; FOV, 360 mm; matrix, 192ϫ156; bandwidth, 789 Hz/px; 30 phases per R-R interval). 13 To test intraobserver variability of CMR planimetry, all examinations were analyzed twice by 1 investigator with a latency of at least 2 months. To test interobserver variability, 2 investigators who were blinded to each others' results analyzed all examinations.
Statistical Analysis
Results are presented as meanϮSD. Correlations between orifice areas obtained by TTE, TEE, and CMR were analyzed using the Spearman rank order correlation test and are displayed as scattergrams with regression lines and 95% CIs. Bland-Altmann analysis and intraclass correlation coefficients (ICC) were used to evaluate the agreement between orifice area measurements according to the 3 methods and to determine observer-related variability. Statistical significance was implied at PϽ0.05. Statistical analyses were performed using SPSS 13.0 (SPSS Inc, Chicago, Ill).
Results
Echocardiographic Assessment of Aortic Bioprostheses
All patients tolerated the procedures well, and no adverse events were encountered. All TTE and TEE examinations had diagnostic image quality.
Mean prosthetic orifice area obtained by TTE was 1.70Ϯ0.43 cm 2 (nϭ65; range, 0.80 to 2.90 cm 2 ) and 1.82Ϯ0.53 cm 2 by TEE (nϭ31; range, 0.73 to 3.13 cm 2 ). Agreement between prosthetic orifice area assessed by TTE and TEE was high (nϭ31; rϭ0.82; PϽ0.001; mean difference, 0.08Ϯ0.27 cm 2 ; ICC, 0.93).
The peak transprosthetic pressure gradient was 27.3Ϯ 16.6 mm Hg (range, 6.0 to 95.0 mm Hg). The mean pressure gradient was 15.0Ϯ9.7 mm Hg (range, 3.0 to 59.0 mm Hg).
Feasibility of CMR to Image Aortic Bioprostheses
Of the 65 patients who entered the study and underwent CMR, the image quality was diagnostic in 62 patients (95.4%). Excellent image quality was obtained in 52 patients (80.0%) ( Figure 2 ; video file 1), whereas in 10 patients (15.4%), image quality was reduced due to artifacts caused by stent material (nϭ3), sternal cerclages (nϭ1), and turbulent flow (nϭ6) (Figure 3 ; video files 2 to 3). In 4 of the 6 patients with significant flow artifacts using the standard SSFP technique, additional FGRE sequences were applied. In 2 of them, flow artifacts were significantly reduced using the FGRE technique, thus enabling CMR planimetry with results comparable to TTE in both cases (Figure 4 ). Severe flow artifacts prevented CMR planimetry in 3 cases (4.6%), leaving 62 patients for further analyses.
Quantification of Prosthetic Orifice Area by CMR and TTE
Mean prosthetic orifice area obtained by CMR was 1.71Ϯ0.46 cm 2 (nϭ62; range, 0.76 to 3.23 cm 2 ) and showed strong agreement with TTE results (nϭ62; rϭ0.82; PϽ0.001) ( Figure 5 ). The mean absolute difference between CMR-and TTE-derived prosthetic orifice areas was Ϫ0.02Ϯ0.24 cm 2 (nϭ62; range, Ϫ0.62 to 0.62 cm 2 ; ICC, 0.92) ( Figure 6 ).
Quantification of Prosthetic Orifice Area by CMR and TEE
Prosthetic orifice areas correlated significantly between TEE and CMR (nϭ29; rϭ0.92; PϽ0.001) ( Figure 5 ). The mean absolute difference between TEE-and CMR-derived prosthetic orifice areas was 0.05Ϯ0.15 cm 2 (nϭ29; range, Ϫ0.24 to 0.37 cm 2 ; ICC, 0.98) ( Figure 6 ).
Comparison of Stentless and Stented Prostheses
CMR results showed strong agreement with echocardiographic data with respect to both stented and stentless prostheses. The mean difference for stented devices using CMR in comparison with TTE and TEE was Ϫ0.02Ϯ0.22 cm 2 (ICC, 0.86) and 0.07Ϯ0.15 cm 2 (ICC, 0.95), respectively. The mean difference for stentless prostheses was Ϫ0.04Ϯ0.28 cm 2 (ICC, 0.94) and 0.02Ϯ0.15 cm 2 (ICC, 0.98), respectively. Repeated measurements of prosthetic orifice area by 1 investigator resulted in an intraobserver variability of 6.7Ϯ5.4% (range, 0.0 to 23.5%; ICC, 0.97). Assessment by 2 blinded observers revealed an interobserver variability of 11.5Ϯ7.8% (range, 0.0 to 24.3%; ICC, 0.93) (Figure 7 ).
Discussion
In both routine clinical 14, 15 and research applications, 16 -18 evaluation of the hemodynamic performance of a bioprosthesis mainly depends on transprosthetic pressure gradients and orifice area. Pressure gradients are strongly flow dependent and thus vary greatly with left ventricular filling state and systolic function. 19 Furthermore, these gradients may be elevated even in a normally functioning prosthesis in the case of patient-prosthesis mismatch. 20 -22 In contrast, prosthetic orifice area is widely flow-independent and can discriminate stenotic from normally opening prostheses but requires the calculated pressure gradient information to diagnose patientprosthesis mismatch. Thus, it requires a comprehensive evaluation of left ventricular function, pressure gradients, and orifice area to best describe the hemodynamic performance of a heart valve prosthesis. Whereas pressure gradients are usually obtained reliably using TTE, the echocardiographic assessment of orifice area sometimes remains a challenge. We therefore designed our study to assess the feasibility of CMR to quantify the orifice area of bioprostheses.
Echocardiographic Assessment of the Prosthetic Orifice Area of Bioprostheses
Transthoracic echocardiography using the continuity equation is the established clinical standard with which to calcu-late prosthetic orifice area 1,2 and will remain the method of first choice because of its ready availability, noninvasiveness, and accuracy. The latter was reconfirmed by our results that showed close agreement with TEE. However, the present study only included patients with an acceptable acoustic window. In contrast, sternotomy, obesity, pulmonary disease, and prosthetic artifacts are sometimes encountered in routine clinical practice and may lead to inaccurate transthoracic measurements; this is partly reflected in the large standard deviations of the mean reference orifice areas published for each type of heart valve prosthesis. 23 TEE is the only validated alternative if TTE remains nondiagnostic. 4, 24 How- ever, many patients perceive TEE to be unpleasant because of its semi-invasive nature, and TEE planimetry of the orifice area can be complicated by difficulties in obtaining the correct crosssectional view of the prosthetic cusps. 25 In the future, 3-dimensional imaging techniques may improve the ability to quantify prosthetic valve area by echocardiography, 26, 27 but these techniques have not yet entered routine clinical practice. Thus, a noninvasive alternative to assess prosthetic orifice area in selected patients is desirable.
Feasibility of CMR to Assess the Prosthetic Orifice Area of Bioprostheses
We have demonstrated that CMR with standard SSFP sequences was technically capable of visualizing transprosthetic blood flow as well as the opening and closing of aortic bioprostheses. The CMR image quality was diagnostic for quantification of orifice area in the majority of patients (95.4%). These measurements were largely independent of the patients' physique, explaining the higher proportion of diagnostic examinations obtained compared with TTE, which remained nondiagnostic because of insufficient acoustic windows in 11% of the patients both in the present study sample with aortic valve replacement and in patients with native aortic valve disease. 5 Compared with TEE, which was diagnostic in all patients, the efficacy of CMR to visualize the bioprostheses correctly was slightly lower. This difference was due to cases in which turbulent blood flow and associated artifacts negatively impaired CMR quality, whereas the image quality of TEE in brightness mode is independent of flow. Interestingly, the assessment of native aortic valves using CMR was reported to result in diagnostic image quality in a higher percentage compared with the study of bioprostheses, 5, 6 leading to the assumption that it is the presence of the bioprostheses that promotes significant turbulent flow and causes image artifact.
Challenges of CMR When Imaging Aortic Bioprostheses
In the 13 cases with less than excellent CMR quality, the suboptimal CMR image quality could be explained by artifacts caused by the physical change of having an aortic valve bioprosthesis. Each aortic bioprosthesis constitutes a left ventricular outflow obstacle, leading to turbulent transprosthetic flow and causing flow artifacts of varying significance. It is well known that the SSFP sequence is more susceptible to flow phenomena than FGRE. Nevertheless, SSFP is generally the preferred sequence for assessing bioprostheses because of its superior signal-to-noise ratio, clear-cut bloodtissue contrast, and high spatial and temporal resolution, making the accurate identification of the fast-moving delicate valve cusps easier. 28, 29 Schlosser et al 30 demonstrated that the assessment of aortic valve stenoses using SSFP correlates better with TEE compared with FGRE. However, when flow artifacts render SSFP images of nondiagnostic quality, we showed that the application of FGRE can improve image quality and allow image analysis in select cases. However, one possible limitation of this study was that we did not systematically apply FGRE because head-to-head comparison of the various sequences was beyond the scope of this investigation. Thus, our single experiences with FGRE do not allow us to draw general conclusions about its accuracy to quantify prosthetic orifice areas compared with echocardiography and SSFP.
A second source of image artifacts was surgical foreign bodies, for example, sternal wires and the struts of stented prostheses. The latter, however, did not lead to nondiagnostic examinations in any case. In fact, the agreement of CMR with TTE and TEE was similar for both stented and stentless prostheses. The dark stent silhouette even facilitated the manual contouring of the orifice area in some cases because it enhanced the contrast between systolic flow and prosthetic apparatus.
Finally, 19% of all initially screened patients were excluded from the study because of general contraindications for CMR (electric device, clinical state, obesity). In these subgroups, TEE remains the preferred method to assess the bioprosthesis if TTE is inconclusive. However, the number of patients who are excluded from CMR imaging will presumably decrease in the future as image acquisition becomes faster and wider-bore gantries of the CMR scanner become available.
Accuracy of CMR to Quantify the Orifice Area of Aortic Bioprostheses
Our results demonstrate that CMR planimetry of aortic bioprosthetic orifice area correlates highly with data obtained by TTE and TEE planimetry. The agreement between CMR and echocardiography to assess aortic bioprostheses was similar to that of other reports describing the successful application of CMR to the assessment of native aortic valves (rϭ0.96; mean difference, 0.17Ϯ0.15 cm 2 comparing CMR with TTE; rϭ0.99; Ϫ0.1Ϯ0.3 cm 2 comparing CMR with TEE). 5, 6, 31 Whereas CMR and TEE assess the largest anatomic orifice area during systole, TTE quantifies the effective orifice area, that is, the area of flow stream as it passes through the valve, and calculates the mean over the entire systolic ejection period. 12 This different methodical approach should in theory lead to closer agreement between orifice areas obtained by CMR and TEE and to a systematic overestimation using TEE and CMR when compared with TTE. In agreement with this hypothesis, our data showed closer agreement between CMR and TEE than between CMR and TTE. However, we did not reveal systematic bias between CMR and TTE. It is likely, therefore, that minor measurement inaccuracies compensate for the systematic difference expected between both methods.
Analysis of the agreement between CMR and TTE revealed a 95% CI of Ϯ0.48 cm 2 . This means that by using these methods, our ability to distinguish normal from abnormal results could be compromised in individual patients. Consensus review and subsequent TEE demonstrated that incorrect TTE measurements were the source of error in all 3 cases that fell beyond the limits of agreement. The erroneous calculations were attributable to the incorrect measurement of the left ventricular outflow tract diameter in 2 patients with structural valve deterioration and incorrect Doppler measure-ments in 1 patient with severe prosthetic regurgitation. In 3 other patients with intermethod differences larger than 0.30 cm 2 , orifice areas obtained by TEE confirmed the CMR results. Exclusion of these cases reduces the CI to Ϯ0.30 cm 2 , underlining that the large CI is attributed to limitations of TTE and emphasizing the need for a noninvasive alternative in selected patients.
Agreement between CMR and echocardiography was present both for stentless and stented prostheses, with slightly larger ICC for stentless devices. The superiority of stentless prostheses can be explained by the absence of prosthetic stent material that can cause flow turbulences and stent artifacts.
CMR and echocardiography showed strong agreement that was independent of prosthetic size and prosthetic orifice area. However, the study sample only contained 2 patients with orifice areas Յ1.0 cm 2 , corresponding to published freedom rates from structural valve deterioration ranging from 97% to 100% after 5 years. 32, 33 Thus, further studies in patients with severe prosthetic stenosis and other prosthetic complications are necessary to extend the appropriateness of CMR planimetry to these subgroups.
Interobserver analyses revealed a 95% CI of Ϯ0.50 cm 2 , which is mainly attributed to measurement differences in subjects with mean interobserver orifice areas larger than 1.8 cm 2 . This finding is partly explained by the lower blood flow velocity through larger orifice areas, which leads to decreased contrast between blood and prosthetic cusps and therefore complicates cusp border delineation. In addition, in large orifice areas, small differences in manual prosthetic border tracing cause larger absolute differences in orifice area than in small orifice areas. Both technical limitations must be considered when applying CMR planimetry to bioprostheses. When excluding patients with orifice areas larger than 1.8 cm 2 from the present sample, the CI of interobserver dependency decreases to Ϯ0.24 cm 2 . In general, the interobserver and intraobserver variabilities of CMR planimetry were low and within the range of accepted echocardiographic results that report 5% to 8% variability for experienced observers examining native aortic valves. 27 The high reproducibility and reliability of CMR planimetry can be attributed to the standardized approach during slice positioning, the definite determination of the planimetry plane, and the high spatial resolution of CMR providing well-defined prosthetic orifice borders.
Conclusion
We demonstrated the feasibility of CMR to assess the orifice area of aortic bioprostheses in a broad variety of prosthetic types and sizes with normal orifice areas. Our data showed high agreement with TTE and TEE and low observer dependency. Therefore, CMR has the potential to become a valuable diagnostic tool with which to assess aortic bioprostheses both in routine clinical practice, particularly for patients with uncertain echocardiographic findings, and in clinical research focusing on prosthetic hemodynamics and patient-prosthesis mismatch. Further clinical studies are required to evaluate whether the present results would extend to patients with significant prosthetic dysfunction.
Limitations of the Study
Apart from 1 case of severe regurgitation and 2 cases of severe stenosis, the study sample did not include patients with abnormal and significantly stenotic bioprostheses. Prosthetic dysfunction may be associated with increased turbulent flow. Thus, flow artifacts may occur in a higher percentage than observed in the present series and the percentage of nondiagnostic image quality by CMR may increase. Therefore, to extend the use of CMR to the assessment of dysfunctional prostheses, larger clinical trials are required to test the feasibility of CMR in patients with prosthetic complications. Furthermore, our study sample did not include patients with significantly depressed left ventricular function in whom assessment of valve stenosis using TTE may be more difficult. Therefore, further studies are necessary to fully determine the benefit of CMR compared with TTE when assessing prosthetic orifice area in patients with severely depressed left ventricular function.
